Molecule

The BioDAO Model: Strengths and Weaknesses

Longevity Biotech, Network States, and The DeSci Revolution | Sebastian Brunemeier

Stefan Adolf | Headlessly Minting IP-NFTs and IP Tokens for Developers

Molecule - A New Era of Drug Development I Decentralized Science (DeSci)

Decentralised Science on Decentralised Knowledge Graphs | Jurij Skornik & Charlie Edwards

BioDAOs | 3 Years in - What have we Learned? (Panel Session)

Catalyst Researcher AMA

Investor Panel: Seeking Alpha in DeSci 2024

Revolutionizing Drug Development for Rare Diseases Through AI | Alok Tayi

Democratizing Early-Stage Research Funding: Inside Catalyst, Molecule’s DeSci Funding Machine

Agents Making a Living on Prediction Markets (Gnosis Chain) | Peter Jung

Funding of Translational Research in Germany from the Scientists Perspective | Dr. Maryna Polyakova

Scaling Know How: Barrierless Acceleration to the bio/acc Future | Martin Karlsson

Opportunities for DeSci in the Context of Emerging Network Sovereigns | Lou de Kerhuelvez

Artan Bio IPT | Differences in Traditional Biotech Fundraising vs IPTs (Panel)

The BioDAO Model: Strengths and Weaknesses

Empowering Biotech Leaders: From Academic Science to Accelerated Startups | Julia Zhao

Decentralizing Healthcare Data Management: Hippocrat's Vision for Data Sovereignty

Scientific Progress Through Decentralized AI | Vincent Weisser

DeSci DAOchitectures for Accelerating Science and Innovations | Mark Melnykowicz

Catalyst Researcher AMA: Project Transfidelity Funding Goal Reached

Nucleate Activator Teams Pitch Competition | Molecule x Nucleate

Rewriting Incentives: ResearchHub’s Paid Peer Review Program | Riccardo Goldoni

From Vision to Reality: AthenaDAO's Contributions to Women's Health | Inês Silva

Hacking Mental Wellness: Building HappyDAO to Democratize Mental Health Solutions | Andreas Melhede

Lab.Bio - Accessible BioML Tools, Ownable Discoveries | Niklas Rindtorff

An Introduction to Decentralized Biobanking | Caspar Barnes

Introducing Catalyst